Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMP
Go back to Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMP| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.38 +0.21 (5.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.17 | 52 Week High | $16.89 | |||
| Open | $4.27 | 52 Week Low | $7.35 | |||
| Day High | $4.48 | P/E | N/A | |||
| Day Low | $4.23 | EPS | $-2.35 | |||
| Volume | 1,113,792 | |||||
